Persistence Partners

Persistence Partners

Persistence Partners, originally Great Pacific Capital, based itself in Carpinteria, California, sourcing from the entrepreneurial corridor spanning Santa Barbara and Ventura Counties. The firm funded early-stage companies whose teams applied technology to discrete operational problems. The website confirms the fund has fully deployed, made its final investment, and is not evaluating new opportunities. Strategy centered on seed and start-up stages, targeting capital-efficient models with a clear path to value realization. Portfolio exits, as listed by the firm, span healthcare, enterprise software, and diagnostics: acquisitions include BioIQ (by LetsGetChecked), an unnamed asset by Symphony Technology Group, and a company bought by Becton, Dickinson and Company (NYSE: BDX); a fourth holding completed an IPO. The firm did not disclose fund sizes or check sizes. Scale remains undisclosed beyond the count of four realized outcomes. No team headcount, adjacent vehicles, or operational events appear in available records. The firm a footnote from the Southern California early-stage scene rather than an active allocator. Persistence Partners’ structural differentiator is its terminal posture: a venture firm that has explicitly ceased fundraising and new deal-making, pivoting purely to asset management and exit monitoring. This frozen state makes it a portfolio-cultivation vehicle with a finite lifespan, rather than an ongoing investment platform.